SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1

Wang, Q., Guo, Y., Schwanz, L. T., Mellis, I. A., Sun, Y., Qu, Y., Urtecho, G., Valdez, R., Stoneman, E., Gordon, A., Wang, H. H., Ho, D. D., & Liu, L. (2024). SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1. Emerging Microbes & Infections, 13(1). https://doi.org/10.1080/22221751.2024.2359004
Authors:
Qian Wang
Yicheng Guo
Logan T Schwanz
Ian A Mellis
Yiwei Sun
Yiming Qu
Guillaume Urtecho
Riccardo Valdez
Emily Stoneman
Aubree Gordon
Harris H Wang
David D Ho
Lihong Liu
Affiliated Authors:
Qian Wang
Yicheng Guo
Logan T Schwanz
Ian A Mellis
Yiwei Sun
Yiming Qu
Guillaume Urtecho
Harris H Wang
David D Ho
Lihong Liu
Columbia Affiliation:
Subjects:
SARS-CoV-2 (MeSH)
Spike Glycoprotein, Coronavirus (MeSH)
COVID-19 (MeSH)
Antibodies, Neutralizing (MeSH)
Antibodies, Viral (MeSH)
Immune Evasion (MeSH)
Author Keywords:
covid-19
sars-cov-2
eg.5.1
jn.1
ba.2.87.1
polyclonal sera
mrna vaccines
antibody evasion
receptor engagement
viral infectivity
polyclonal sera; mrna vaccines
elink
Publication Type:
Article
Unique ID:
10.1080/22221751.2024.2359004
PMID:
38779718
DOI:
10.1080/22221751.2024.2359004
Journal:
Emerging Microbes and Infections
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: